REGISTERED NUMBER: 11368668 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

ETHOS PHARMACEUTICAL ETHICS AND

COMPLIANCE LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTOR:

Dr N B Broughton

REGISTERED OFFICE:

Second Floor South

The Fitted Rigging House

Anchor Wharf, The Historic Dockyard

Chatham

Kent

ME4 4TZ

REGISTERED NUMBER:

11368668 (England and Wales)

ACCOUNTANTS:

Carleys

Second Floor South

The Fitted Rigging House

The Historic Dockyard

Chatham

Kent

ME4 4TZ

FIXED ASSETS

Intangible assets

4

145,870

150,821

Tangible assets

5

6,524

3,905

152,394

154,726

CURRENT ASSETS

Debtors

6

79,469

35,117

Cash at bank

369,832

354,639

449,301

389,756

CREDITORS

Amounts falling due within one year

7

203,041

251,749

NET CURRENT ASSETS

246,260

138,007

TOTAL ASSETS LESS CURRENT LIABILITIES

398,654

292,733

CREDITORS

Amounts falling due after more than one year

8

-

(4,121

)

PROVISIONS FOR LIABILITIES

(1,631

)

(976

)

NET ASSETS

397,023

287,636

CAPITAL AND RESERVES

Called up share capital

9

100

100

Retained earnings

396,923

287,536

SHAREHOLDERS' FUNDS

397,023

287,636

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 12 December 2025 and were signed by:

Dr N B Broughton - Director

1.	STATUTORY INFORMATION

Ethos Pharmaceutical Ethics And Compliance Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets

Development expenditure is written off to the profit and loss account in the year in which it is incurred, unless the directors are satisfied as to the technical, commercial and financial viability on specific projects. In this situation, the expenditure is capitalised and amortised using the straight-line method over the period during which the company is expected to benefit.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

Straight line over 3 years

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 4 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

At 1 April 2024

169,938

Additions

12,041

At 31 March 2025

181,979

AMORTISATION

At 1 April 2024

19,117

Charge for year

16,992

At 31 March 2025

36,109

NET BOOK VALUE

At 31 March 2025

145,870

At 31 March 2024

150,821

5.	TANGIBLE FIXED ASSETS

Fixtures

and

fittings

£

COST

At 1 April 2024

9,128

Additions

6,185

At 31 March 2025

15,313

DEPRECIATION

At 1 April 2024

5,223

Charge for year

3,566

At 31 March 2025

8,789

NET BOOK VALUE

At 31 March 2025

6,524

At 31 March 2024

3,905

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

55,900

21,016

Other debtors

23,569

14,101

79,469

35,117

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

-

4,553

Trade creditors

16,704

23,992

Amounts owed to group undertakings

95,263

3,893

Taxation and social security

62,416

104,663

Other creditors

28,658

114,648

203,041

251,749

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

-

4,121

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

100

Ordinary

£1

100

100

10.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

During the year the company advanced a loan to a director totalling £351 (2024: £57) and received repayments totalling £692 (2024: £Nil). At the year end the director was owed £284 by the company (2024: £57 owed by the director).

11.	RELATED PARTY DISCLOSURES

As at the balance sheet date the company owed its parent company, Green Bear Medical Limited, £95,263 (2024: £3,893).

12.	ULTIMATE CONTROLLING PARTY

The ultimate parent company and controlling party is Green Bear Medical Limited, a company registered in England and Wales.